Risk Management

Giant Cell Arteritis Toolkit (2022)

Allegations of failure to diagnose are common in medical malpractice lawsuits against ophthalmologists. Some ophthalmic conditions, such as giant cell arteritis (GCA), have a short window for diagnosis and treatment. The patient then risks severe bilateral vision loss, and the treating ophthalmologist incurs liability exposure.

OMIC offers the following tools, developed by board member Ron Pelton, MD, to help ophthalmologists strengthen their diagnostic and patient management process for GCA:

Giant Cell Arteritis Checklist

·         Helps prompt questions to ask patients during the work-up, and track completion of key tests and consults.

GCA Pt Info Sheet with Consent-Refusal

·         Supports communication to patients of signs and symptoms to watch for and instructions for contacting the ophthalmologist. Includes a sample form to document the patient’s understanding of GCA in general and consent or refusal to proceed with treatment in general. 


Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Supporting your specialty.

OMIC was founded by members of the American Academy of Ophthalmology nearly a quarter century ago and is the only carrier sponsored and endorsed by AAO. OMIC is also endorsed by 54 other ophthalmic societies. The OMIC partnerships with state and subspecialty societies qualifies their members for an exclusive 10% premium credit. Contact your state society for details.